MBOT
Microbot Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 0
Consensus Rating "Strong Buy"
Ample Liquidity
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MBOT
Microbot Medical Inc.
A pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body
Healthcare Equipment and Supplies
08/02/1988
03/27/1992
NASDAQ Stock Exchange
21
12-31
Common stock
175 Derby St., Bld. 27, Hingham, MA 02043
--
Microbot Medical Inc., was incorporated in Delaware on August 2, 1988. The company is a preclinical medical device company specializing in the research, design and development of next-generation robotic intracavitary surgical instruments in the field of minimally invasive surgery. The company is mainly focused on leveraging its robotics technology, with the goal of redefining surgical robotics while improving surgical outcomes for patients. The company's current technology platforms LIBERTY, NovaCross, One & DoneTM, ViRobTM and TipCTTM consist of proprietary and innovative technologies. The company has 58 issued/allowed patents and 51 pending patents around the world, of which 6 issued/allowed patents and 34 patent applications are related to the LIBERTY device.
Company Financials
EPS
MBOT has released its 2025 Q3 earnings. EPS was reported at -0.07, versus the expected -0.06, missing expectations. The chart below visualizes how MBOT has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
